Sign in
Enrolling by invitationNo phase

Brain Stimulation and Attention Control in Children With ADHD

Key facts

Who runs it
Neurolab Plus
Where
Kazakhstan2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
40 people, planned
Started
4 Sept 2025
Planned end
Jun 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Intermittent Theta Burst Stimulation to Right DLPFC
  • Sham Intermittent Theta Burst Stimulation
Record updated
19 September 2025

Who can take part

Age
6 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Children aged 6-12 years at the time of enrollment
  • Clinical diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD), any presentation type, confirmed using the Vanderbilt ADHD Diagnostic Parent Rating Scale and clinical interview
  • Intelligence quotient (IQ) ≥ 70 as measured by the General Ability Index (GAI) from the Wechsler Intelligence Scale for Children - Fifth Edition (WISC-V)
  • Ability to understand and follow instructions for the Attention Network Test (ANT) and stimulation procedure
  • Stable medication regimen for ADHD (if any) for at least 4 weeks before the start of the study
  • Written informed consent from a parent or legal guardian, and assent from the child when appropriate

Who cannot take part

  • Presence of metal implants, devices, or foreign bodies in or near the head (except dental fillings) that are contraindicated for TMS or MRI
  • History of epilepsy, seizures, or abnormal EEG suggestive of seizure risk
  • Serious neurological disorders other than ADHD (e.g., cerebral palsy, brain injury, neurodegenerative disease)
  • Severe psychiatric disorders requiring hospitalization or urgent intervention
  • Current or past history of significant head trauma with loss of consciousness > 5 minutes
  • Uncorrected hearing or vision problems that could interfere with task performance

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if brain stimulation can help children ages 6 to 12 with attention-deficit/hyperactivity disorder (ADHD) improve their attention and self-control. The main questions it aims to answer are:

Read full original descriptionShow less

Does intermittent theta burst stimulation (iTBS) improve performance on a task that tests attention and reaction times? Can brain activity and genetics help predict who benefits most from this treatment?

Researchers will compare randomly assigned active iTBS to sham (inactive) stimulation groups to see if the treatment helps.

Participants will:

Receive 10 sessions of either active or sham iTBS over 2 weeks Complete a computer task measuring attention before and after stimulation Wear a brain cap during the task to record EEG signals, also take part in resting-state brain scans, namely magnetic resonance imaging (MRI) and functional near-infrared spectroscopy (fNIRS), and provide a saliva sample for genetic testing

The 2 groups in the trial

  • Active iTBS to Right DLPFCTreatment being tested

    Participants receive active intermittent theta burst stimulation (iTBS) to the right dorsolateral prefrontal cortex (DLPFC). Each session includes 600 pulses delivered in 2-second trains of 50 Hz bursts (triplets at 5 Hz), repeated every 10 seconds for a total duration of approximately 3 minutes, at 80% of active motor threshold. A total of 10 sessions is administered across two weeks.

    Treatment: Intermittent Theta Burst Stimulation to Right DLPFC

  • Sham iTBS (Right DLPFC)Sham treatment, for comparison

    Participants receive sham stimulation over the right DLPFC using the same coil orientation, session structure, and auditory cues as the active iTBS group, but without magnetic field induction. Ten sham sessions are delivered over two weeks to maintain blinding and control for placebo effects.

    Treatment: Sham Intermittent Theta Burst Stimulation

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of iTBS on Cognitive Control in Children With ADHD: A Randomized, Sham-Controlled Study Integrating EEG During ANT, fNIRS, MRI, and Genetic Markers
Criteria questions
Built from NCT07182344, who can take part
Record updated
19 September 2025